August 4, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 563
Oyster Point, with AbbVie and Novartis in its sights, wins first FDA approval for nasal spray to treat dry eye disease | Fierce Pharma
Xiidra vs. Restasis: Differences, similarities, and which is better for you
Cequa Ophthalmic Solution: Package Insert / Prescribing Information - Drugs.com
Surprise! Viatris Proves Its Worth With First Generic Restasis Approval :: Generics Bulletin
Teva's Generic Restasis Could Punish Allergan (NYSE:AGN) | Seeking Alpha
Allergan, Inc. v. Teva Pharms.: Federal Court Invalidates Allergan Patents as Obvious - Harvard Journal of Law & Technology
US federal judge invalidates Allergan patents on Restasis - Pharmaceutical Business review
Cyclosporine (Restasis): Basics, Side Effects & Reviews
Allergan and Mohawk tribe ask SCOTUS to review controversial Restasis patent licensing deal | Fierce Pharma
BioCentury - Generic Restasis, subject of failed sovereign immunity bid, approved
This billion-dollar dry eye drug is behind Allergan's controversial patent deal - MarketWatch
Allergan pushes FDA to defend Restasis from early generics | Fierce Pharma
FDA Approves Vuity, the First Eye Drop to Treat Presbyopia - Eyewire+
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA Teva Pharmaceuticals USA, Inc., Plaintiff, v. Alex M. Azar II,
Canada Cloud Pharmacy | Trusted Canadian Online Pharmacy
Mylan: Did The FDA Clear The Runway For Generic Restasis? (NASDAQ:VTRS) | Seeking Alpha
Cyclosporine (Restasis): Basics, Side Effects & Reviews
FDA Approves First Generic Formulation of Restasis - Eyewire+
Teva's Generic Restasis Could Punish Allergan (NYSE:AGN) | Seeking Alpha
Patent Docs: FDA Approves Generic Restasis
FDA Set To Make Key Decision On Restasis Generics :: Generics Bulletin
Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease
Restasis Side Effects: Common, Severe, Long Term - Drugs.com
FDA approves first Restasis generic
FDA approves Kala's Eysuvis for dry eye syndrome
FDA Approves Restasis Generic for Dry Eye - GoodRx
